Literature DB >> 7496598

Immunohistochemical localisation of stem cell factor (SCF) with comparison of its receptor c-Kit proto-oncogene product (c-KIT) in melanocytic tumours.

H Takahashi1, K Saitoh, H Kishi, P G Parsons.   

Abstract

In order to characterise the distribution and role of stem cell factor (SCF), a recently-reported growth factor for normal melanocytes, we carried out an immunohistochemical study on benign and malignant melanocytic tumours with a comparison with the presence of its receptor c-Kit proto-oncogene product (c-KIT). In normal skin, SCF was mainly observed in endothelial cells of blood vessels but not frequently in basal melanocytes, whereas c-KIT was predominantly localised in tissue mast cells. In benign neoplastic melanocytes (common melanocytic naevi), localisation of SCF and c-KIT was complementary: SCF was mostly found in dermal naevus cells while c-KIT was revealed in epidermal naevus cells, although the expression of the latter antigen was not frequent. Malignant melanoma cells showed less frequent expression of these antigens than those in benign lesions. Of five cultured melanoma cell lines, SCF was observed in only one, and c-KIT was not found in any melanoma cells. No quantitative or qualitative alterations assessed by Western blot analysis were induced in the presence of phenotypic modifiers (sodium butyrate and HMBA). Present data suggest that loss of SCF expression in neoplastic melanocytes is commonly associated with malignant transformation of pigment cells rather than loss of its receptor c-KIT.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7496598     DOI: 10.1007/bf00203396

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  26 in total

Review 1.  Oncogenes and signal transduction.

Authors:  L C Cantley; K R Auger; C Carpenter; B Duckworth; A Graziani; R Kapeller; S Soltoff
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

2.  bFGF is the putative natural growth factor for human melanocytes.

Authors:  R Halaban; S Ghosh; A Baird
Journal:  In Vitro Cell Dev Biol       Date:  1987-01

3.  Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms.

Authors:  D M Anderson; S D Lyman; A Baird; J M Wignall; J Eisenman; C Rauch; C J March; H S Boswell; S D Gimpel; D Cosman
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

4.  Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells.

Authors:  R Halaban; J S Rubin; Y Funasaka; M Cobb; T Boulton; D Faletto; E Rosen; A Chan; K Yoko; W White
Journal:  Oncogene       Date:  1992-11       Impact factor: 9.867

5.  Rapid and reversible inhibition of tyrosinase activity by glucosidase inhibitors in human melanoma cells.

Authors:  H Takahashi; P G Parsons
Journal:  J Invest Dermatol       Date:  1992-04       Impact factor: 8.551

6.  Loss of c-kit expression in cultured melanoma cells.

Authors:  N Lassam; S Bickford
Journal:  Oncogene       Date:  1992-01       Impact factor: 9.867

7.  Isomers of a marine diterpene distinguish sublines of human melanoma cells on the basis of apoptosis, cell cycle arrest and differentiation markers.

Authors:  H Takahashi; R Schumann; R Quinn; T A Briscoe; P G Parsons
Journal:  Melanoma Res       Date:  1992 Jan-Feb       Impact factor: 3.599

8.  Human dermal endothelial cells express membrane-associated mast cell growth factor.

Authors:  R R Weiss; D Whitaker-Menezes; J Longley; J Bender; G F Murphy
Journal:  J Invest Dermatol       Date:  1995-01       Impact factor: 8.551

9.  Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.

Authors:  Y Yarden; W J Kuang; T Yang-Feng; L Coussens; S Munemitsu; T J Dull; E Chen; J Schlessinger; U Francke; A Ullrich
Journal:  EMBO J       Date:  1987-11       Impact factor: 11.598

10.  Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor.

Authors:  D Becker; C B Meier; M Herlyn
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

View more
  6 in total

1.  KIT protein expression and mutational status of KIT gene in pituitary adenomas.

Authors:  Olivera Casar-Borota; Stine Lyngvi Fougner; Jens Bollerslev; Jahn Marthin Nesland
Journal:  Virchows Arch       Date:  2012-01-03       Impact factor: 4.064

2.  Stem cell factor restores hepatocyte proliferation in IL-6 knockout mice following 70% hepatectomy.

Authors:  Xiaodan Ren; Cory Hogaboam; Audra Carpenter; Lisa Colletti
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

3.  Expression of SCF splice variants in human melanocytes and melanoma cell lines: potential prognostic implications.

Authors:  P Welker; D Schadendorf; M Artuc; J Grabbe; B M Henz
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

4.  Autocrine/Paracrine Loop Between SCF+/c-Kit+ Mast Cells Promotes Cutaneous Melanoma Progression.

Authors:  Tiziana Annese; Roberto Tamma; Mariella Bozza; Alfredo Zito; Domenico Ribatti
Journal:  Front Immunol       Date:  2022-01-24       Impact factor: 7.561

5.  Expression of c-kit protein in cancer vs. normal breast tissue.

Authors:  Abdolhassan Talaiezadeh; Seyed Nematollah Jazayeri; Jamal Nateghi
Journal:  Contemp Oncol (Pozn)       Date:  2012-09-29

6.  Treatment of gastrointestinal stromal tumor: focus on imatinib mesylate.

Authors:  Omar S Din; Penella J Woll
Journal:  Ther Clin Risk Manag       Date:  2008-02       Impact factor: 2.423

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.